The Decline Theory in neurology states that the pathophysiology of neurological diseases results in an overall decrease in brain activity. It is an alternative to the Excitotoxicity Theory, which suggests that increased neuron activity is a primary cause of neurodegenerative diseases. The Decline Theory suggests that the decrease in brain activity is due to decreased synaptic communication between neurons and a decreased release of neurotransmitters. There are three main components of the Decline Theory. First, neuronal networks and connections become weakened as the interactions between neurons slow down. This results in less information being exchanged between neurons leading to a decrease in brain activity. Secondly, decreased release of neurotransmitters can occur due to a decrease in neurotransmitter production, or because of neuronal dysfunction. Finally, the degeneration of axons can lead to disruption and damage to neural networks resulting in a decrease of brain activity. The Decline Theory has been proposed in neurological diseases such as Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease. It is often suggested to be a more comprehensive explanation for the pathogenesis of these diseases than the Excitotoxicity Theory, as it takes into account both the decreased activity of neurons and the decline in the networks that these neurons are connected to. In addition, the Decline Theory suggests that therapies for neurological diseases should focus on both restoring the function of existing neurons and connecting them effectively, as well as forming new, strong neuronal networks. This differs from the Excitotoxicity Theory, which suggests therapies should focus solely on restoring excitatory activity. A better understanding of the molecular pathways and mechanisms of the Decline Theory could lead to improved treatments and interventions for neurological diseases.
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : ADNP regulates cortical development: Mechanism of ADNP syndrome/autism
Kazuhito Toyooka, Drexel University College of Medicine, United States
Title : Mild cognitive impairment (MCI) in Parkinson’s disease: Prevalence given MDS criteria
Cay Anderson Hanley, iPACES, United States
Title : Modeling early neurologic trajectories after elevated leg positioning (ELP): A secondary analysis of the LEG-UP randomized feasibility study
Kayode Ahmed, The University of Texas MD Anderson Cancer Center, United States
Title : Neuro-exergaming for non-verbal autism spectrum: A case study of neuropsychological function after 15 sessions of pedal-n-play iPACES
Cay Anderson Hanley, iPACES, United States
Title : Prescribing joy: The importance of integrating memory cafes into dementia care
Saul Beaumont, Massachusetts Advisory Council on Alzheimer's Disease and All Other Dementias, United States